While large human trials are pending, preclinical and mechanistic evidence is strong
Combining with other products Stacking Integrative Peptides BPC-157 with their TB4-Frag product follows the same rationale as combining injectable BPC-157 with TB-500
The studies span decades and cover diverse injury types
Research organizations, distributors, and procurement teams need a supplier capable of maintaining product consistency, reliable availability, and efficient order fulfillment
Your dosing, duration, and monitoring are personalized based on your goals and health history
This is based on its ability to counteract ketamine and MK-801, NMDA receptor antagonists that model negative-like schizophrenia symptoms in rodents